Direct activation of protein phosphatase-2A(0) by HIV-1 encoded protein complex NCp7:vpr

被引:43
作者
Tung, HYL
DeRocquigny, H
Zhao, LJ
Cayla, X
Rogues, BP
Ozon, R
机构
[1] CFSR BIOMED SCI INST,PROT & PEPTIDE RES LAB,HOUSTON,TX 77068
[2] CNRS,INSERM,U266,DEPT PHARMACOCHIM MOL & STRUCT,URA D 1500,F-75006 PARIS,FRANCE
[3] ST LOUIS UNIV,CTR HLTH SCI,SCH MED,INST MOL VIROL,ST LOUIS,MO 63110
关键词
Protein phosphatase-2A; HIV-1; NCp7; vpr;
D O I
10.1016/S0014-5793(96)01470-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of HIV-1 encoded proteins NCp7, vpr and NCp7:vpr complex on the activity of protein phosphatase-2A(0) have been tested, We report that NCp7 is an activator of protein phosphatase-2A(0) and that vpr activated protein phosphatase-2A(0) only slightly, We also report that NCp7 and vpr form a tight complex which becomes a more potent activator of protein phosphatase-2A(0) than NCp7 alone, The ability of NCp7 to activate protein phosphatase-2A(0) is regulated by vpr. The C-terminal portion of vpr prevents NCp7 from activating protein phosphatase-2A(0) while the N-terminal portion of vpr potentiates the effect of NCp7 on the activity of protein phosphatase-2A(0), Our findings indicate that vpr may be acting as a targeting subunit which directs NCp7 to activate protein phosphatase-2A(0), In view of the fact that protein phosphatase-2A functions as an inhibitor of G(0) to M transition of the cell cycle and is involved in other key cellular processes such as the control of RNA transcription, the results presented in this report may explain how HIV-1 causes cell cycle arrest which may lead to CD4+ T cell depletion and also how it disturbs normal cellular processes of its host cell.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 33 条
  • [1] PROTEIN PHOSPHATASE-2A POTENTIATES ACTIVITY OF PROMOTERS CONTAINING AP-1-BINDING ELEMENTS
    ALBERTS, AS
    DENG, TL
    LIN, AN
    MEINKOTH, JL
    SCHONTHAL, A
    MUMBY, MC
    KARIN, M
    FERAMISCO, JR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (04) : 2104 - 2112
  • [2] MUTATIONS OF RNA AND PROTEIN SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING RESULT IN PRODUCTION OF NONINFECTIOUS VIRUS
    ALDOVINI, A
    YOUNG, RA
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (05) : 1920 - 1926
  • [3] HIV-1 REVERSE-TRANSCRIPTASE SPECIFICALLY INTERACTS WITH THE ANTICODON DOMAIN OF ITS COGNATE PRIMER TRANSFER-RNA
    BARAT, C
    LULLIEN, V
    SCHATZ, O
    KEITH, G
    NUGEYRE, MT
    GRUNINGERLEITCH, F
    BARRESINOUSSI, F
    LEGRICE, SFJ
    DARLIX, JL
    [J]. EMBO JOURNAL, 1989, 8 (11) : 3279 - 3285
  • [4] Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control
    Bartz, SR
    Rogel, ME
    Emerman, M
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (04) : 2324 - 2331
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] PHOSPHATASE 2A ASSOCIATED WITH POLYOMAVIRUS SMALL-T OR MIDDLE-T ANTIGEN IS AN OKADAIC ACID-SENSITIVE TYROSYL PHOSPHATASE
    CAYLA, X
    BALLMERHOFER, K
    MERLEVEDE, W
    GORIS, J
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01): : 281 - 286
  • [7] THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
    COHEN, P
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 : 453 - 508
  • [8] OKADAIC ACID - A NEW PROBE FOR THE STUDY OF CELLULAR-REGULATION
    COHEN, P
    HOLMES, CFB
    TSUKITANI, Y
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (03) : 98 - 102
  • [9] COHEN P, 1988, METHOD ENZYMOL, V159, P390
  • [10] 1ST LARGE-SCALE CHEMICAL SYNTHESIS OF THE 72 AMINO-ACID HIV-1 NUCLEOCAPSID PROTEIN NCP7 IN AN ACTIVE FORM
    DEROCQUIGNY, H
    FICHEUX, D
    GABUS, C
    FOURNIEZALUSKI, MC
    DARLIX, JL
    ROQUES, BP
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (02) : 1010 - 1018